MedPath

Evaluation effects of Zinc sulfate and Hydroxyzine in pruritus treatment of hemodialysis patients

Phase 2
Conditions
Pruritus of Hemodialysis patients.
End-stage renal disease
Registration Number
IRCT201411252954N5
Lead Sponsor
Vice chancellor for research, Shahroud University medical and Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
100
Inclusion Criteria

chronic pruritus refractory to other treatments over 4 weeks. In the last 2 weeks in 1 month moisturizing cream and antihistamines to relieve itching liver. Patients have not used.

  Exclusion criteria: drug intolerance - a kidney transplant before the end of the study - Hyperparathyroidism - increased ALK, sensitivity to any of the above medications, Patient dissatisfaction

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity Pruritus. Timepoint: Twice a weeks. Method of measurement: Visual Analog Scor(VAS).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath